Earnings Preview For Ituran Location & Control

Ituran Location & Control (NASDAQ:ITRN) is set to give its latest quarterly earnings report on Monday, 2022-11-21. Here’s…

Ituran Location & Control (NASDAQ:ITRN) is set to give its latest quarterly earnings report on Monday, 2022-11-21. Here’s what investors need to know before the announcement.

Analysts estimate that Ituran Location & Control will report an earnings per share (EPS) of $0.46.

Ituran Location & Control bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.04, which was followed by a 3.28% drop in the share price the next day.

Here’s a look at Ituran Location & Control’s past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.47 0.47 0.46 0.43
EPS Actual 0.43 0.43 0.46 0.46
Price Change % -3.28% 1.99% -5.35% -6.12%

eps graph

Stock Performance

Shares of Ituran Location & Control were trading at $22.75 as of November 17. Over the last 52-week period, shares are down 12.77%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Ituran Location & Control visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CBD Of Denver’s Success In Challenging Climate With Increase In Q4 Revenue

CBD of Denver has reported strong fourth-quarter revenues of approximately $1.31m, with $1.13m generated by Luxora and $176,000 by Libra 9. The CBD company attributed its growth to a number of factors, including its partnership with EDEKA and the popularity of its Magic Lappen product, both of which increased sales across Germany. CBD of Denver also highlighted the success of Libra 9's attendance at trade shows, which boosted brand recognition and allowed the company to form several significant partnerships. Meanwhile, Luxora's expansion into the European CBD wholesale market was credited with contributing significantly to the company's growth. Following the German government's expected approval of relevant legislation, Luxora Solutions will expand further into the German market. Germany's decision on legalising marijuana, which was set to be made in December, has been delayed until next year.

CBDD